Researchers review the role of microfluidic chip models in understanding neurodegenerative diseases, offering insights into the disease mechanisms and potential for drug development through innovative lab-on-a-chip technologies.
Novartis reportedly backs off acquisition of Cytokinetics – WSJ
After Novartis CEO Vas Narasimhan downplayed rumors that his company wanted to acquire the biotech Cytokinetics, the Wall Street Journal reported Thursday that the Big